Home›Search›Journal of Pharmacoeconomics and Pharmaceutical Management

Journal of Pharmacoeconomics and Pharmaceutical Management

Tehran University of Medical Sciences · Iran, Islamic Republic of

eISSN2383-4498

✓ DOAJ✓ Open Access

/ 100

High Risk

Score Breakdown

✓ DOAJ Verified+15

Total15

Aims & Scope

Journal of Pharmacoeconomics and Pharmaceutical Management (JPPM) is an international peer-reviewed journal, which publishes original research articles, reviews, letters and editorials on all fields of pharmacoeconomics, and pharmaceutical management. JPPM is dedicated to the clear communication of policy and economic issues related to pharmaceutical system, pharmaceutical industries, patient services and rational use of medicines.

General Information

Country / RegionIran, Islamic Republic of

Primary LanguageEnglish

1st Year Published—

FrequencyQuarterly

StatusActive

Total Publications—

Visit Journal Website

Submission Info

Peer ReviewDouble anonymous peer review

Review Time—

Acceptance Rate—

OA LicenseCC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/12 · 67%

✅

Do you know the journal / publisher?

Tehran University of Medical Sciences

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2383-4498

✅

Indexed in a trusted database?

DOAJ

✅

Peer review process documented?

Double anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification

Research Topics (OpenAlex)

Pharmaceutical Economics and PolicyPharmaceutical Quality and CounterfeitingHealth Systems, Economic Evaluations, Quality of LifeAntibiotic Use and ResistanceHealthcare Systems and ReformsEconomic and Financial Impacts of CancerPharmaceutical Practices and Patient OutcomesBiotechnology and Related FieldsAcute Lymphoblastic Leukemia researchLong-Term Effects of COVID-19